Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

Histone deacetylases (HDACs) have emerged as important targets for cancer treatment. HDAC-inhibitors (HDACis) are well tolerated in patients and have been approved for the treatment of patients with cutaneous T-cell lymphoma (CTCL). To improve the clinical benefit of HDACis in solid tumors, combinat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kortenhorst, Madeleine SQ, Wissing, Michel D, Rodriguez, Ronald, Kachhap, Sushant K, Jans, Judith JM, Van der Groep, Petra, Verheul, Henk MW, Gupta, Anuj, Aiyetan, Paul O, van der Wall, Elsken, Carducci, Michael A, Van Diest, Paul J, Marchionni, Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3883768/
https://ncbi.nlm.nih.gov/pubmed/23880963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/epi.25574
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados